183 related articles for article (PubMed ID: 32586692)
1. Switching opioid-dependent patients in substitution treatment from racemic methadone, levomethadone and buprenorphine to slow-release oral morphine: Analysis of the switching process in routine care.
Baschirotto C; Lehmann K; Kuhn S; Reimer J; Verthein U
J Pharmacol Sci; 2020 Sep; 144(1):9-15. PubMed ID: 32586692
[TBL] [Abstract][Full Text] [Related]
2. Substitution treatment for opioid dependence with slow-release oral morphine: Retention rate, health status, and substance use after switching to morphine.
Lehmann K; Kuhn S; Baschirotto C; Jacobsen B; Walcher S; Görne H; Backmund M; Scherbaum N; Reimer J; Verthein U
J Subst Abuse Treat; 2021 Aug; 127():108350. PubMed ID: 34134867
[TBL] [Abstract][Full Text] [Related]
3. Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence.
Hämmig R; Köhler W; Bonorden-Kleij K; Weber B; Lebentrau K; Berthel T; Babic-Hohnjec L; Vollmert C; Höpner D; Gholami N; Verthein U; Haasen C; Reimer J; Ruckes C
J Subst Abuse Treat; 2014 Oct; 47(4):275-81. PubMed ID: 25064422
[TBL] [Abstract][Full Text] [Related]
4. Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone.
Beck T; Haasen C; Verthein U; Walcher S; Schuler C; Backmund M; Ruckes C; Reimer J
Addiction; 2014 Apr; 109(4):617-26. PubMed ID: 24304412
[TBL] [Abstract][Full Text] [Related]
5. Slow-release oral morphine as maintenance therapy for opioid dependence.
Ferri M; Minozzi S; Bo A; Amato L
Cochrane Database Syst Rev; 2013 Jun; (6):CD009879. PubMed ID: 23740540
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and quality of life of opioid-dependent pregnant women in Austria.
Metz VE; Comer SD; Wuerzl J; Pribasnig A; Fischer G
Arch Womens Ment Health; 2014 Dec; 17(6):529-39. PubMed ID: 25023716
[TBL] [Abstract][Full Text] [Related]
7. Sustained release oral morphine as an alternative to methadone for the treatment of opioid-use disorder post Torsades de Pointes cardiac arrest.
Walton G; Nolan S; Sutherland C; Ahamad K
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26392442
[TBL] [Abstract][Full Text] [Related]
8. After the randomised injectable opiate treatment trial: post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication.
Bond AJ; Reed KD; Beavan P; Strang J
Drug Alcohol Rev; 2012 Jun; 31(4):492-8. PubMed ID: 21919979
[TBL] [Abstract][Full Text] [Related]
9. Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): Protocol for a non-inferiority randomized clinical trial.
Socias ME; Wood E; Dong H; Brar R; Bach P; Murphy SM; Fairbairn N
Contemp Clin Trials; 2020 Apr; 91():105993. PubMed ID: 32194251
[TBL] [Abstract][Full Text] [Related]
10. Switching Opioid-Dependent Patients From Methadone to Morphine: Safety, Tolerability, and Methadone Pharmacokinetics.
Glue P; Cape G; Tunnicliff D; Lockhart M; Lam F; Gray A; Hung N; Hung CT; Harland S; Devane J; Howes J; Weis H; Friedhoff L
J Clin Pharmacol; 2016 Aug; 56(8):960-5. PubMed ID: 26763764
[TBL] [Abstract][Full Text] [Related]
11. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
[TBL] [Abstract][Full Text] [Related]
12. Mental symptoms and drug use in maintenance treatment with slow-release oral morphine compared to methadone: results of a randomized crossover study.
Verthein U; Beck T; Haasen C; Reimer J
Eur Addict Res; 2015; 21(2):97-104. PubMed ID: 25427944
[TBL] [Abstract][Full Text] [Related]
13. Assessing the impact of the slow-release oral morphine drug shortages in Ontario, Canada: A population-based time series analysis.
Ledlie S; Tadrous M; McCormack D; Campbell T; Leece P; Kleinman RA; Kolla G; Besharah J; Smoke A; Sproule B; Gomes T
Int J Drug Policy; 2023 Aug; 118():104119. PubMed ID: 37429161
[TBL] [Abstract][Full Text] [Related]
14. Uptake of slow-release oral morphine as opioid agonist treatment among hospitalised patients with opioid use disorder.
Brothers TD; Fraser J; MacAdam E; Morgan B; Webster D
Drug Alcohol Rev; 2022 Feb; 41(2):430-434. PubMed ID: 34347327
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomized, parallel group study to compare the efficacy, safety and tolerability of slow-release oral morphine versus methadone in opioid-dependent in-patients willing to undergo detoxification.
Madlung-Kratzer E; Spitzer B; Brosch R; Dunkel D; Haring C
Addiction; 2009 Sep; 104(9):1549-57. PubMed ID: 19686525
[TBL] [Abstract][Full Text] [Related]
16. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
Kastelic A; Dubajic G; Strbad E
Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
[TBL] [Abstract][Full Text] [Related]
17. Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series.
Nielsen S; Bruno R; Degenhardt L; Demirkol A; Lintzeris N
Drug Alcohol Rev; 2017 May; 36(3):311-316. PubMed ID: 27273511
[TBL] [Abstract][Full Text] [Related]
18. Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence.
Mitchell TB; White JM; Somogyi AA; Bochner F
Addiction; 2004 Aug; 99(8):940-5. PubMed ID: 15265090
[TBL] [Abstract][Full Text] [Related]
19. Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol.
Terasaki D; Smith C; Calcaterra SL
Pharmacotherapy; 2019 Oct; 39(10):1023-1029. PubMed ID: 31348544
[TBL] [Abstract][Full Text] [Related]
20. One size does not fit all-evolution of opioid agonist treatments in a naturalistic setting over 23 years.
Nordt C; Vogel M; Dey M; Moldovanyi A; Beck T; Berthel T; Walter M; Seifritz E; Dürsteler KM; Herdener M
Addiction; 2019 Jan; 114(1):103-111. PubMed ID: 30209840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
